{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:48:25Z","timestamp":1775659705960,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","award":["PID2022-136438OB-I00"],"award-info":[{"award-number":["PID2022-136438OB-I00"]}],"id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","award":["PDC2022-133269-I00"],"award-info":[{"award-number":["PDC2022-133269-I00"]}],"id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/ https:\/\/doi.org\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/ https:\/\/doi.org\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019370","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002911","name":"Universidad Complutense de Madrid","doi-asserted-by":"publisher","award":["910939"],"award-info":[{"award-number":["910939"]}],"id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijpharm.2026.126749","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:10:53Z","timestamp":1773159053000},"page":"126749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of self-emulsifying drug delivery systems (SEDDS) to improve the bioavailability of a new antileishmanial drug"],"prefix":"10.1016","volume":"695","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1857-5222","authenticated-orcid":false,"given":"Almudena","family":"Laguna","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-9191","authenticated-orcid":false,"given":"Adriana O.","family":"Santos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-0619","authenticated-orcid":false,"given":"M\u00e1rcio","family":"Rodrigues","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-0714","authenticated-orcid":false,"given":"Gilberto","family":"Alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-1932","authenticated-orcid":false,"given":"Christophe","family":"Dardonville","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-2615","authenticated-orcid":false,"given":"Santiago","family":"Torrado-Santiago","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-3367","authenticated-orcid":false,"given":"Carlos","family":"Torrado-Salmer\u00f3n","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2026.126749_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103085","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) of Apremilast: in vitro evaluation and pharmacokinetics studies","volume":"27","author":"Abushal","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2026.126749_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/colloids7010016","article-title":"Recent advances in improving the bioavailability of hydrophobic\/lipophilic drugs and their delivery via self-emulsifying formulations","author":"Ameta","year":"2023","journal-title":"Colloids Interfaces"},{"key":"10.1016\/j.ijpharm.2026.126749_b0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejps.2016.04.018","article-title":"Development and application of an ex vivo fosphenytoin nasal bioconversion\/permeability evaluation method","volume":"89","author":"Antunes Viegas","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0020","article-title":"Self-nanoemulsifying drug delivery system (Snedds) for improved oral bioavailability of chlorpromazine: In vitro and in vivo evaluation","volume":"55","author":"Baloch","year":"2019","journal-title":"Medicina (lithuania)"},{"key":"10.1016\/j.ijpharm.2026.126749_b0025","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.xphs.2024.06.014","article-title":"A stratified analysis of supersaturation and precipitation effects based on the refined developability classification system (rDCS)","volume":"113","author":"Beran","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070353","article-title":"Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis","volume":"11","author":"Bezerra-Souza","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120377","article-title":"Effects of different physicochemical characteristics and supersaturation principle of solidified SNEDDS and surface-modified microspheres on the bioavailability of carvedilol","volume":"597","author":"Choi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0040","doi-asserted-by":"crossref","unstructured":"Dahlgren, D., Lennern\u00e4s, H., 2019. Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches. Pharmaceutics 2019, Vol. 11, Page 411 11, 411. DOI: 10.3390\/PHARMACEUTICS11080411.","DOI":"10.3390\/pharmaceutics11080411"},{"key":"10.1016\/j.ijpharm.2026.126749_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2010.03.040","article-title":"In vitro methods to assess drug precipitation","author":"Dai","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0050","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-022-02291-z","article-title":"Self-emulsifying systems for delivery of bioactive compounds from natural origin","author":"de Oliveira","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2026.126749_b0055","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.2147\/DDDT.S335122","article-title":"A validated hplc-ms\/ms method for quantification of methotrexate and application for therapeutic drug monitoring in children and adults with non-hodgkin lymphoma","volume":"15","author":"Feng","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijpharm.2026.126749_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009196","article-title":"2-Aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling","volume":"15","author":"Ferreira","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpharm.2026.126749_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-024-01769-6","article-title":"Simvastatin is delivered to the brain by high-strength intranasal cationic SMEDDS and nanoemulsions","author":"Gama","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpharm.2026.126749_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28196962","article-title":"Revisiting supersaturation of a biopharmaceutical classification system IIB drug: evaluation via a multi-cup dissolution approach and molecular dynamic simulation","volume":"28","author":"Gan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2026.126749_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1208\/s12249-021-02085-9","article-title":"Preparation and evaluation of self-emulsifying drug delivery system (SEDDS) of cepharanthine","volume":"22","author":"Gao","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2026.126749_b0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17425255.2021.1951223","article-title":"Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity","volume":"17","author":"Gaohua","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196176","article-title":"Direct in vitro comparison of the anti-leishmanial activity of different olive oil total polyphenolic fractions and assessment of their combined effects with miltefosine","volume":"27","author":"Gogou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2026.126749_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020283","article-title":"Application of design of experiments in the development of self-microemulsifying drug delivery systems","author":"Hsieh","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpharm.2026.126749_b0095","first-page":"339","article-title":"Review on self micro emulsifying drug delivery system(SMEDDS)","volume":"2","author":"Jadhav Bharat","year":"2024","journal-title":"Int. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13346-022-01247-x","article-title":"Self-nanoemulsifying formulation for oral delivery of sildenafil: effect on physicochemical attributes and in vivo pharmacokinetics","volume":"13","author":"Jain","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpharm.2026.126749_b0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejps.2018.06.002","article-title":"Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum","volume":"121","author":"Jim\u00e9nez-Ant\u00f3n","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.111098","article-title":"Design and development of permeation enhancer containing self-nanoemulsifying drug delivery system (SNEDDS) for ceftriaxone sodium improved oral pharmacokinetics","volume":"289","author":"Kanwal","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2026.126749_b0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/01932691.2023.2190390","article-title":"Design, characterization and pharmacokinetic studies of anti-Malarial drug Artemisinin by optimized self-emulsifying nano drug delivery system (SNEDDS)","volume":"45","author":"Karri","year":"2024","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2478\/acph-2024-0023","article-title":"Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and\/or lower its dose: a review","volume":"74","author":"Kovacevic","year":"2024","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/01932691.2021.1957922","article-title":"Development of pitavastatin-loaded super-saturable self-nano emulsion: a continues screening and optimization approach using statistical technique","volume":"44","author":"Kuncahyo","year":"2023","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/pharmaceutics17070838","article-title":"Development and characterization of a new oral antileishmanial bis(pyridine-2-carboxamidine) drug through innovative dissolution testing in biorelevant media combined with pharmacokinetic studies","volume":"17","author":"Laguna","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0135","article-title":"Formulation approaches for improving the dissolution behavior and bioavailability of tolvaptan using SMEDDS","volume":"14","author":"Lee","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/polym15204184","article-title":"Development of chitosan\/sodium carboxymethylcellulose complexes to improve the simvastatin release rate: polymer\/polymer and drug\/polymer interactions\u2019 effects on kinetic models","volume":"15","author":"L\u00f3pez-Manzanara P\u00e9rez","year":"2023","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ijpharm.2026.126749_b0145","article-title":"Preparation, characterization, and sub-chronic toxicity of carvacrol-self-nano-emulsifying drug delivery system towards healthy sprague dawley rats","volume":"19","author":"Maarouf","year":"2024","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ijpharm.2026.126749_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062827","article-title":"Enhanced intestinal permeability of cefixime by self-emulsifying drug delivery system: in-vitro and ex-vivo characterization","volume":"28","author":"Mahmood","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2026.126749_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121853","article-title":"Intranasal delivery of lipid-based nanosystems as a promising approach for brain targeting of the new-generation antiepileptic drug perampanel","volume":"622","author":"Meirinho","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071487","article-title":"Self-emulsifying drug delivery systems: an alternative approach to improve brain bioavailability of poorly water-soluble drugs through intranasal administration","author":"Meirinho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1852","article-title":"Recent approaches in nanocarrier-based therapies for neglected tropical diseases","author":"Mengarda","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106097","article-title":"Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum","volume":"169","author":"Monteiro","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0175","doi-asserted-by":"crossref","unstructured":"Morakul, B., Teeranachaideekul, V., Limwikrant, W., Junyaprasert, V.B., 2024. Dissolution and antioxidant potential of apigenin self nanoemulsifying drug delivery system (SNEDDS) for oral delivery. Scientific Reports 2024 14:1 14, 8851-. DOI: 10.1038\/s41598-024-59617-z.","DOI":"10.1038\/s41598-024-59617-z"},{"key":"10.1016\/j.ijpharm.2026.126749_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.22159\/ijap.2022v14i2.43692","article-title":"Self-micro emulsifying drug delivery system of ursolic acid: formulation development, characterization, pharmacokinetic and pharmacodynamic studies for diabetic complications","volume":"14","author":"Mouli","year":"2022","journal-title":"Int. J. Appl. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2026.126749_b0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.02.005","article-title":"Proposal of stability categories for nano-dispersions obtained from pharmaceutical self-emulsifying formulations","volume":"446","author":"Niederquell","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0190","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.1c00832","article-title":"Hydroxypropyl cellulose for drug precipitation inhibition: from the potential of molecular interactions to performance considering microrheology","volume":"19","author":"Niederquell","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0195","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1021\/acs.jmedchem.3c00697","article-title":"Synthesis and biophysical and biological studies of N-phenylbenzamide derivatives targeting kinetoplastid parasites","volume":"66","author":"Nu\u00e9-Martinez","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2026.126749_b0200","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c08138","article-title":"Nanostructured lipid carrier for intracellular delivery of a bis(pyridine-2-carboxamidine) DNA minor groove binder active against leishmania","author":"Nu\u00e9-Martinez","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijpharm.2026.126749_b0205","article-title":"On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state","volume":"168","author":"O\u2019Dwyer","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","author":"Pali\u0107","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpharm.2026.126749_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.05.048","article-title":"Trends in advanced oral drug delivery system for curcumin: a systematic review","author":"Pan-On","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2026.126749_b0220","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.2147\/IJN.S464508","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) using lipophilic extract of viscum album subsp. austriacum (Wiesb.) Vollm","volume":"19","author":"de Pereira","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2026.126749_b0225","article-title":"Development of an isoquercitrin-loaded SNEDDS for enhanced oral absorption: a promising non-steroidal therapy for atopic dermatitis","volume":"114","author":"Phuyal","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071878","article-title":"Innovative aqueous nanoemulsion prepared by phase inversion emulsification with exceptional homogeneity","volume":"15","author":"Pires","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u201cself-microemulsifying\u201d drug delivery systems","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0240","doi-asserted-by":"crossref","unstructured":"Priani, S.E., Fakih, T.M., Wilar, G., Chaerunisaa, A.Y., Sopyan, I., 2025. Quality by design and in silico approach in SNEDDS development: a comprehensive formulation framework. Pharmaceutics 2025, Vol. 17, Page 701 17, 701. DOI: 10.3390\/PHARMACEUTICS17060701.","DOI":"10.3390\/pharmaceutics17060701"},{"key":"10.1016\/j.ijpharm.2026.126749_b0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s13346-022-01193-8","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies","volume":"13","author":"Rathore","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpharm.2026.126749_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091064","article-title":"Self-emulsifying drug delivery systems (SEDDS): measuring energy dynamics to determine thermodynamic and kinetic stability","volume":"15","author":"Rehman","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpharm.2026.126749_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124576","article-title":"A novel ultra-sensitive LC-MS\/MS method for determination of elobixibat in human plasma; application to a bioequivalence study on healthy volunteers","volume":"1257","author":"Rezk","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijpharm.2026.126749_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141257","article-title":"Acyl chitosan based self-nanoemulsifying drug delivery system of lipophilic drug with enhanced oral bioavailability and mucoadhesion: formulation development, optimization and in vitro\/in vivo characterization","volume":"306","author":"Sabale","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijpharm.2015.12.002","article-title":"Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: studies in Caco-2 cells and in vivo","volume":"498","author":"Sangsen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874104501105010031","article-title":"Structures, targets and recent approaches in anti-leishmanial drug discovery and development","volume":"5","author":"Seifert","year":"2011","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.ijpharm.2026.126749_b0275","doi-asserted-by":"crossref","DOI":"10.1007\/s40122-023-00529-7","article-title":"Celecoxib oral solution and the benefits of self-microemulsifying drug delivery systems (SMEDDS) technology: a narrative review","author":"Silberstein","year":"2023","journal-title":"Pain Ther."},{"key":"10.1016\/j.ijpharm.2026.126749_b0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40005-018-0385-5","article-title":"Canagliflozin loaded SMEDDS: formulation optimization for improved solubility, permeability and pharmacokinetic performance","volume":"49","author":"Singh","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2026.126749_b0285","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c00693","article-title":"Advancing treatment for leishmaniasis: from overcoming challenges to embracing therapeutic innovations","author":"Singh","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpharm.2026.126749_b0290","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2017.12.014","article-title":"The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens","volume":"124","author":"Siqueira J\u00f8rgensen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0295","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.8b00097","article-title":"Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis","volume":"15","author":"Smith","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0300","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1080\/10717544.2022.2149896","article-title":"Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids","volume":"29","author":"Subedi","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2026.126749_b0305","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-022-02272-2","article-title":"Design and development of solid SMEDDS and liquisolid formulations of lovastatin, for improved drug dissolution and in vivo effects\u2014a pharmacokinetic and pharmacodynamic assessment","volume":"23","author":"Suram","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2026.126749_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120958","article-title":"Biorelevant dissolution testing and physiologically based absorption modeling to predict in vivo performance of supersaturating drug delivery systems","author":"Thakore","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122520","article-title":"Solid dispersions of atorvastatin with Kolliphor RH40: Enhanced supersaturation and improvement in a hyperlipidemic rat model","volume":"631","author":"Torrado-Salmer\u00f3n","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.126749_b0320","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02963-0","article-title":"Absorptio-nenhancing mechanisms of capryol 90, a novel absorption enhancer, for improving the intestinal absorption of poorly absorbed drugs: contributions to trans- or para-cellular pathways","volume":"37","author":"Ukai","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2026.126749_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010063","article-title":"Self-emulsifying drug delivery systems (SEDDS): transition from liquid to solid\u2014a comprehensive review of formulation, characterization, applications, and future trends","author":"Uttreja","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0330","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1093\/jac\/dkad286","article-title":"Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis","volume":"78","author":"Verrest","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2026.126749_b0335","article-title":"Intestinal absorption studies of ORI-SMEDDS with different zeta potentials through lipolysis absorption model in vitro, single pass intestine perfusion and pharmacokinetics","volume":"87","author":"Wang","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2026.126749_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112316","article-title":"Review of novel oral amphotericin B formulations for the treatment of parasitic infections","author":"Wasan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2026.126749_b0345","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-01983-2","article-title":"Self-assembled micelles improve the oral bioavailability of dihydromyricetin and anti-acute alcoholism activity","volume":"22","author":"Ye","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2026.126749_b0350","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.2147\/IJN.S203911","article-title":"Comparisons of in vitro fick\u2019s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS","volume":"14","author":"Ye","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2026.126749_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/nano11112920","article-title":"Development of piperine-loaded solid self-nanoemulsifying drug delivery system: optimization, in-vitro, ex-vivo, and in-vivo evaluation","volume":"11","author":"Zafar","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpharm.2026.126749_b0360","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.xphs.2021.02.030","article-title":"Nanoemulsion for improving the oral bioavailability of hesperetin: formulation optimization and absorption mechanism","volume":"110","author":"Zeng","year":"2021","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517326001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517326001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:53:17Z","timestamp":1775656397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517326001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":72,"alternative-id":["S0378517326001973"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2026.126749","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of self-emulsifying drug delivery systems (SEDDS) to improve the bioavailability of a new antileishmanial drug","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2026.126749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126749"}}